Company Overview and News

 
Mustang Resources eyes first cash flow from world-class vanadium-graphite project in 2019

2018-09-17 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) is fast-tracking its world-class Caula Vanadium-Graphite Project in Mozambique, with first cash flows targeted for H2 of 2019 from trial mining operations.
MUS SRHYY SYR SYAAF

2
Heavyweight finance stocks send ASX to 12 week low

2018-09-13 theage.com.au
The Australian sharemarket closed at a 12-week low on Thursday, as the royal commission continued to weigh on the finance sector.
PMCUF NCMGF WOPEF NCM RIO BLT RIO SRHYY SNDFY BEPTF RTPPF PME SYR RTNTF SFR WNARF WSA BHPBF WPL BCHEY WOPEY SYAAF BPT TNE NCMGY SFRRF BHP RIO BBL BHP BHPLF

2
Heavyweight finance stocks send ASX to 12 week low

2018-09-13 smh.com.au
The Australian sharemarket closed at a 12-week low on Thursday, as the royal commission continued to weigh on the finance sector.
PMCUF NCMGF WOPEF NCM RIO BLT RIO SRHYY SNDFY BEPTF RTPPF PME SYR RTNTF SFR WNARF WSA BHPBF WPL BCHEY WOPEY SYAAF BPT TNE NCMGY SFRRF BHP RIO BBL BHP BHPLF

 
Mustang Resources drilling extends graphite vanadium resource

2018-09-06 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has completed, ahead of schedule, its feasibility study drilling program on the Caula Vanadium-Graphite Project in Mozambique.
MUS SRHYY SYR SYAAF

 
An Update On RNC Minerals

2018-09-04 seekingalpha
Despite the reduction at Dumont down to 28% share, RNC Minerals is still very attractive to investors positive on nickel and cobalt.
PLS RNX PILBF SRHYY SYR SYAAF

 
Syrah in trading halt, unveils $94 million capital raising

2018-09-04 theage.com.au
Australian graphite company Syrah Resources has announced a $94 million capital raising, the proceeds of which will be used to finish the ramp up of its graphite operation in Mozambique, fund plans to enter fast-growing electric battery markets and other costs.
SRHYY SYR SYAAF

 
Syrah in trading halt, unveils $94 million capital raising

2018-09-04 smh.com.au
Australian graphite company Syrah Resources has announced a $94 million capital raising, the proceeds of which will be used to finish the ramp up of its graphite operation in Mozambique, fund plans to enter fast-growing electric battery markets and other costs.
SRHYY SYR SYAAF

 
Mustang Resources to outline shift in focus to battery metals at Proactive CEO Sessions

2018-09-03 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) is shifting its focus to the key battery metals of vanadium and graphite and this process involves a proposed name change to New Energy Minerals Ltd (ASX:NXE).
MUS SRHYY SYR FUGMF SYAAF

2
Vanadium Miners News For The Month Of August 2018

2018-08-29 seekingalpha
Vanadium market news - Vanadium market expected to grow, fueled by strong steel and increasing energy storage demands.
AVL SRHYY GLCNF KRC PRPCF TON NMT CCC APPPF SYR EFR AEE RDRUY ATVVF UUUU AUEEF LGO APAFF LGORF AMVMF SYAAF RRSSF BSHVF CCCCF bmn

18
Graphite Miners News For The Month Of August 2018

2018-08-28 seekingalpha - 1
Graphite market news - "The graphite electrode market is expected to sustain its growth momentum in the current year (2018-19) as the demand-supply gap is expected to widen."
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF RNU ABGPF GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG ALP LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF

 
Mustang Resources begins feasibility drilling at Caula Vanadium-Graphite Project

2018-08-08 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has begun a drilling program at its Caula project in northern Mozambique, with over 4,000 metres planned for completion this quarter.
MUS SRHYY SYR SYAAF

2
ASX closes flat despite BHP hitting near-four year high

2018-07-31 theage.com.au
The Australian sharemarket rebounded from a loss inside the opening hour to close the day flat, with gains in the material and energy sectors.
WOPEF RIO BLT RIO OISHY SRHYY BHPBF WTCHF WPL RGRNF WOPEY SYAAF OISHF RTPPF BHP RIO SYR RRL RTNTF BBL BHP BHPLF OSH

2
ASX closes flat despite BHP hitting near-four year high

2018-07-31 smh.com.au
The Australian sharemarket has rebounded from a loss inside the opening hour to close the day flat, with gains in the material and energy sectors.
WOPEF RIO BLT RIO OISHY SRHYY BHPBF WTCHF WPL RGRNF WOPEY SYAAF OISHF RTPPF BHP RIO SYR RRL RTNTF BBL BHP BHPLF OSH

2
Vanadium Miners News For The Month Of July 2018

2018-07-30 seekingalpha
Vanadium market news - Navigant - "VRB to be one of the fastest growing electrochemical storage technology sets over the next decade."
AVL SRHYY KRC PRPCF TON NMT CCC APPPF SYR EFR AEE RDRUY UUUU ATVVF AUEEF LGO APAFF LGORF AMVMF SYAAF RRSSF BSHVF CCCCF bmn

 
Australian shares fall as miners tumble

2018-07-30 theage.com.au
Australian shares dropped on Monday under the weight of selling in mid-cap mining stocks following a weak set of numbers from short-seller target and graphite producer Syrah Resources.
SFRRF SRHYY SNDFY SYR SFR IGO IIDDY SYAAF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:SYR / SYRAH RESOURCES LIMITED on message board site Silicon Investor.

Israel to U.S. : Now Deal with Syria and Iran Israel to U.S. : Now Deal with Syria and Iran Israel to U.S. : Now Deal with Syria and Iran Syria and Iran are next Syria and Iran are next Syria and Iran are next
MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology EZR: Easyriders, Inc. EZR: Easyriders, Inc. EZR: Easyriders, Inc.
EZR Easyriders EZR Easyriders EZR Easyriders Newriders, Inc (NWRD) Easyriders Restaurant Newriders, Inc (NWRD) Easyriders Restaurant Newriders, Inc (NWRD) Easyriders Restaurant
Safety Needles/Safety Syringes Safety Needles/Safety Syringes Safety Needles/Safety Syringes